Top Small Cap Stocks To Own For 2019

tags:SIGI,PCRX,IMGN,

Small cap restaurant stock Potbelly Corp (NASDAQ: PBPB) reported�Q2 2017 earnings before the market opened on Friday with the bottom line missing expectations. Total revenues increased 3.0% to $108.1 million as company-operated comparable store sales decreased 4.9%. Sixteen new shops opened, including three franchised shops and thirteen company-operated shops. The GAAP net loss attributable to Potbelly Corporation was $0.1 million versus�net income of $3.4 million (inclusive of a $1.0 million impairment charge). The CFO/interim-CEO commented:

"During the second quarter, we generated revenue of $108 million, an increase of 3%, driven by our new unit growth, offset by the impact of our comparable store sales, which decreased 4.9%. While disappointed with our top-line performance, we are encouraged by our ability to manage costs, drive solid flow-through delivering shop-level profit margin of 19.2%, and generate adjusted EBITDA of $11.8 million."

Top Small Cap Stocks To Own For 2019: Selective Insurance Group, Inc.(SIGI)

Advisors' Opinion:

• [By Shane Hupp]

  BidaskClub downgraded shares of Selective Insurance (NASDAQ:SIGI) from a hold rating to a sell rating in a report published on Monday.

  A number of other equities research analysts have also issued reports on SIGI. ValuEngine upgraded shares of Selective Insurance from a hold rating to a buy rating in a report on Friday, February 2nd. Keefe, Bruyette & Woods set a $62.00 price target on shares of Selective Insurance and gave the stock a hold rating in a research note on Monday, February 5th. Zacks Investment Research downgraded shares of Selective Insurance from a buy rating to a hold rating in a report on Wednesday, March 14th. Sandler O’Neill reaffirmed a hold rating and set a $61.00 price objective on shares of Selective Insurance in a report on Friday, April 6th. Finally, Boenning Scattergood reaffirmed a hold rating on shares of Selective Insurance in a report on Thursday, May 3rd. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $62.50.

• [By Shane Hupp]

  Selective Insurance (NASDAQ:SIGI) – Boenning Scattergood decreased their Q2 2018 earnings per share estimates for shares of Selective Insurance in a research note issued to investors on Thursday, May 3rd. Boenning Scattergood analyst R. Farnam now expects that the insurance provider will earn $0.83 per share for the quarter, down from their prior estimate of $0.96. Boenning Scattergood has a “Hold” rating on the stock. Boenning Scattergood also issued estimates for Selective Insurance’s Q4 2018 earnings at $1.04 EPS, Q1 2019 earnings at $0.88 EPS, Q2 2019 earnings at $0.85 EPS, Q3 2019 earnings at $0.98 EPS and Q4 2019 earnings at $1.05 EPS.

Top Small Cap Stocks To Own For 2019: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors' Opinion:

• [By Jon C. Ogg]

  Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid treatment has become an elusive target. And it’s too bad when you consider how many people have become addicted to opioids in America.

• [By Stephan Byrd]

  ValuEngine upgraded shares of Pacira Pharmaceuticals (NASDAQ:PCRX) from a sell rating to a hold rating in a research note published on Thursday morning.

Top Small Cap Stocks To Own For 2019: ImmunoGen, Inc.(IMGN)

Advisors' Opinion:

• [By Logan Wallace]

  ImmunoGen (NASDAQ:IMGN) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday.

• [By Brian Orelli]

  Shares of ImmunoGen (NASDAQ:IMGN) fell 9.2% on Thursday after the biotech announced�yesterday after the bell that it was selling 13.7 million shares for $11 per share. The underwriters have an option to purchase an additional 2.055 million shares, potentially further diluting current shareholders.

• [By Joseph Griffin]

  Trexquant Investment LP raised its stake in shares of ImmunoGen (NASDAQ:IMGN) by 190.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 331,215 shares of the biotechnology company’s stock after buying an additional 217,244 shares during the quarter. Trexquant Investment LP owned about 0.25% of ImmunoGen worth $3,484,000 at the end of the most recent reporting period.

• [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M